Monopar Therapeutics Inc. (MNPR)

NASDAQ: MNPR · IEX Real-Time Price · USD

0.657

+0.007 (1.08%)

At close: Apr 24, 2024, 4:00 PM

0.630

-0.027 (-4.06%)

After-hours: Apr 24, 2024, 5:38 PM EDT

Monopar Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	-8.4	-10.52	-9.1	-6.3	-4.22	-3.23	-16.55	-1.19
Share-Based Compensation	1.9	1.64	1.47	1.32	1.01	0.53	0.31	0
Other Operating Activities	-1.35	1.65	0.32	0.32	0.2	0.02	13.62	-0.01
Operating Cash Flow	-7.86	-7.23	-7.32	-4.66	-3.02	-2.68	-2.63	-1.19
Change in Investments	4.93	-4.92	0	0	0	0	0	0
Investing Cash Flow	4.93	-4.92	0	0	0	0	0	0
Share Issuance / Repurchase	2.07	0.11	10.94	8.18	9.36	-0.21	4.71	0
Debt Issued / Paid	0	0	0	0.12	0	0	0	0
Other Financing Activities	-0.05	-0.08	-0.06	-0.12	-0.01	-	4.83	1.26
Financing Cash Flow	2.03	0.03	10.88	8.18	9.35	-0.21	9.54	1.26
Exchange Rate Effect	-0.02	-0	0	0	-0.01	-0	0	0
Net Cash Flow	-0.92	-12.12	3.57	3.52	6.32	-2.89	6.91	0.07
Free Cash Flow	-7.86	-7.23	-7.32	-4.66	-3.02	-2.68	-2.63	-1.19
Free Cash Flow Per Share	-0.57	-0.57	-0.59	-0.42	-0.32	-0.29	-0.30	-0.13

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).